Analysts Set Healthcare Realty Trust Incorporated (NYSE:HR) PT at $19.75

Healthcare Realty Trust Incorporated (NYSE:HR) has received an average rating of “Hold” from the ten ratings firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $20.25.

Several analysts recently commented on the stock. Citigroup increased their price objective on shares of Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Scotiabank increased their price objective on shares of Healthcare Realty Trust from $20.00 to $22.00 and gave the company an “outperform” rating in a research report on Friday, May 8th. UBS Group increased their price objective on shares of Healthcare Realty Trust from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday. Weiss Ratings lowered shares of Healthcare Realty Trust from a “hold (c)” rating to a “sell (d+)” rating in a report on Monday, May 4th. Finally, Cantor Fitzgerald boosted their price objective on shares of Healthcare Realty Trust from $21.00 to $22.00 and gave the stock an “overweight” rating in a report on Monday, May 4th.

Healthcare Realty Trust Trading Down 0.5%

Shares of NYSE:HR opened at $20.27 on Wednesday. The stock has a fifty day simple moving average of $18.30 and a two-hundred day simple moving average of $17.80. The stock has a market capitalization of $7.02 billion, a price-to-earnings ratio of -34.94 and a beta of 0.97. Healthcare Realty Trust has a 12-month low of $14.09 and a 12-month high of $20.52.

Healthcare Realty Trust (NYSE:HR) last announced its quarterly earnings data on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.02. Healthcare Realty Trust had a negative return on equity of 4.29% and a negative net margin of 17.34%.The business had revenue of $275.28 million during the quarter, compared to analysts’ expectations of $283.01 million. During the same quarter in the previous year, the business earned $0.39 earnings per share. The firm’s quarterly revenue was down 7.7% compared to the same quarter last year. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. As a group, equities research analysts predict that Healthcare Realty Trust will post 1.61 EPS for the current year.

Healthcare Realty Trust Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 22nd. Investors of record on Monday, May 11th will be given a dividend of $0.24 per share. The ex-dividend date of this dividend is Monday, May 11th. This represents a $0.96 annualized dividend and a dividend yield of 4.7%. Healthcare Realty Trust’s dividend payout ratio (DPR) is -165.52%.

Insider Activity at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian acquired 10,000 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The shares were bought at an average cost of $18.09 per share, with a total value of $180,900.00. Following the completion of the transaction, the director directly owned 85,520 shares of the company’s stock, valued at approximately $1,547,056.80. This represents a 13.24% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.56% of the stock is owned by company insiders.

Institutional Investors Weigh In On Healthcare Realty Trust

Institutional investors have recently modified their holdings of the business. Dynamic Technology Lab Private Ltd purchased a new position in shares of Healthcare Realty Trust during the first quarter valued at approximately $205,000. Empowered Funds LLC purchased a new position in shares of Healthcare Realty Trust in the 1st quarter worth $202,000. Invesco Ltd. boosted its stake in shares of Healthcare Realty Trust by 48.9% in the 2nd quarter. Invesco Ltd. now owns 2,307,109 shares of the real estate investment trust’s stock worth $36,591,000 after buying an additional 757,542 shares during the last quarter. First Trust Advisors LP boosted its stake in shares of Healthcare Realty Trust by 314.1% in the 2nd quarter. First Trust Advisors LP now owns 223,125 shares of the real estate investment trust’s stock worth $3,539,000 after buying an additional 169,248 shares during the last quarter. Finally, Amundi boosted its stake in shares of Healthcare Realty Trust by 154.0% in the 2nd quarter. Amundi now owns 519,816 shares of the real estate investment trust’s stock worth $8,343,000 after buying an additional 315,179 shares during the last quarter.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.